Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats
Stewart H. Lecker, … , William E. Mitch, Alfred L. Goldberg
Stewart H. Lecker, … , William E. Mitch, Alfred L. Goldberg
Published November 15, 1999
Citation Information: J Clin Invest. 1999;104(10):1411-1420. https://doi.org/10.1172/JCI7300.
View: Text | PDF
Article Article has an altmetric score of 3

Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats

  • Text
  • PDF
Abstract

Insulin deficiency (e.g., in acute diabetes or fasting) is associated with enhanced protein breakdown in skeletal muscle leading to muscle wasting. Because recent studies have suggested that this increased proteolysis is due to activation of the ubiquitin-proteasome (Ub-proteasome) pathway, we investigated whether diabetes is associated with an increased rate of Ub conjugation to muscle protein. Muscle extracts from streptozotocin-induced insulin-deficient rats contained greater amounts of Ub-conjugated proteins than extracts from control animals and also 40–50% greater rates of conjugation of 125I-Ub to endogenous muscle proteins. This enhanced Ub-conjugation occurred mainly through the N-end rule pathway that involves E214k and E3α. A specific substrate of this pathway, α-lactalbumin, was ubiquitinated faster in the diabetic extracts, and a dominant negative form of E214k inhibited this increase in ubiquitination rates. Both E214k and E3α were shown to be rate-limiting for Ub conjugation because adding small amounts of either to extracts stimulated Ub conjugation. Furthermore, mRNA for E214k and E3α (but not E1) were elevated 2-fold in muscles from diabetic rats, although no significant increase in E214k and E3α content could be detected by immunoblot or activity assays. The simplest interpretation of these results is that small increases in both E214k and E3α in muscles of insulin-deficient animals together accelerate Ub conjugation and protein degradation by the N-end rule pathway, the same pathway activated in cancer cachexia, sepsis, and hyperthyroidism.

Authors

Stewart H. Lecker, Vered Solomon, S. Russ Price, Yong Tae Kwon, William E. Mitch, Alfred L. Goldberg

×

Figure 4

Options: View larger image (or click on image) Download as PowerPoint
Depletion of E3α from rabbit reticulocyte extract by an anti E3α antiser...
Depletion of E3α from rabbit reticulocyte extract by an anti E3α antiserum. Rabbit reticulocyte fraction II (50 μg) was mixed with buffer, preimmune IgG (3 μg), or anti-E3α IgG (3 μg), and rotated at 4°C for 30 hours. Protein A agarose (3 μL) was added to each sample and incubated an additional 3 hours at 4°C. After sedimentation of the agarose beads, the supernatant and washed beads were separately analyzed. (a) Anti-E3α immunoblot of postimmunoprecipitation supernatants. Supernatants of the above reactions were subjected to 8% SDS-PAGE, probed with anti E3α IgG at a dilution of 1:2000. Treatment of the extract with anti E3α IgG specifically removed a 200-kD immunoreactive band. (b) E3α activity was depleted from the postimmunoprecipitation supernatants after treatment with anti-E3α IgG. Supernatants of the above reactions were supplemented with AMPPNP (2 mM), Ub (25 μM), Ub aldehyde (1 μM), E1 (0.1 μM), E214k (5 μM), and 125I-α-lactalbumin (∼0.75 μM). In the presence of LysAla (2 mM), a competitive inhibitor of E3α, no Ub-conjugation activity is seen (lanes 4–6). In the presence of the isomeric dipeptide, AlaLys (2 mM), which does not inhibit E3α, 125I-α-lactalbumin-Ub conjugates were formed after buffer addition (lane 1) or after immunoprecipitation with preimmune IgG (lane 2). However, after immunoprecipitation with anti-E3α IgG, most of the E3α activity was abolished. (c) Pellets after anti-E3α IgG immunoprecipitation contained E3α activity. Washed protein A agarose beads from the above reactions (4-fold increase in amounts) were supplemented with AMPPNP (2 mM), Ub (25 μM), E1 (0.1 μM), E214k (10 μM), and 125I-α-lactalbumin (∼0.75 μM). Only the beads that contained anti-E3α IgG supported formation of 125I-α-lactalbumin-Ub conjugates.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
46 readers on Mendeley
See more details